Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Local chemotherapeutic agents for the treatment of ocular malignancies.

Fernandes BF, Nikolitch K, Coates J, Novais G, Odashiro A, Odashiro PP, Belfort RN, Burnier MN Jr.

Surv Ophthalmol. 2014 Jan-Feb;59(1):97-114. doi: 10.1016/j.survophthal.2013.01.003. Epub 2013 Oct 8. Review.

PMID:
24112549
2.

Treatment of CIN with retinoic acid and topical interferon alfa-2b.

Huerva V.

Ophthalmology. 2013 Aug;120(8):e55. doi: 10.1016/j.ophtha.2013.05.023. No abstract available.

PMID:
23916085
3.

Recurrent intraepithelial neoplasia treatment.

Schechter BA, Nagler RS, Schrier A.

Ophthalmology. 2005 Jul;112(7):1319; author reply 1319. No abstract available.

PMID:
15993243
4.

Successful treatment with 5-Fu.

Schechter BA, Nagler RS.

Ophthalmology. 2003 Apr;110(4):625-6; author reply 626. No abstract available. Corrected and republished in: Ophthalmology. 2003 Jun;110(6):1262-3; author reply 1263.

PMID:
12689863
5.

Topical medical therapies for ocular surface tumors.

Poothullil AM, Colby KA.

Semin Ophthalmol. 2006 Jul-Sep;21(3):161-9. Review.

PMID:
16912014
6.

Successful treatment with 5-Fu.

Schechter BA, Nagler RS.

Ophthalmology. 2003 Jun;110(6):1262-3; author reply 1263. No abstract available.

PMID:
12799258
7.

Author reply: To PMID 22704834.

Coroneo M.

Ophthalmology. 2013 Aug;120(8):e55-6. doi: 10.1016/j.ophtha.2013.05.022. No abstract available.

PMID:
23916086
8.

Antimetabolites in ocular surface neoplasia.

Majmudar PA, Epstein RJ.

Curr Opin Ophthalmol. 1998 Aug;9(4):35-9. Review.

PMID:
10387466
9.

Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.

Krilis M, Tsang H, Coroneo M.

Ophthalmology. 2012 Oct;119(10):1969-73. doi: 10.1016/j.ophtha.2012.03.045. Epub 2012 Jun 14.

PMID:
22704834
10.

Topical chemotherapy for ocular surface squamous neoplasia.

Nanji AA, Sayyad FE, Karp CL.

Curr Opin Ophthalmol. 2013 Jul;24(4):336-42. doi: 10.1097/ICU.0b013e3283622a13. Review.

PMID:
23680759
11.
12.

[Treatment with topical interferon alone in severe conjunctivo-corneal neoplasia].

Díaz-Valle D, Benítez-del-Castillo JM, Díaz-Valle T, Poza-Morales Y, Arteaga-Sánchez A.

Arch Soc Esp Oftalmol. 2005 Dec;80(12):729-32. Spanish.

PMID:
16372217
13.

Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.

Schechter BA, Koreishi AF, Karp CL, Feuer W.

Ophthalmology. 2008 Aug;115(8):1291-6, 1296.e1. doi: 10.1016/j.ophtha.2007.10.039. Epub 2008 Jan 9.

PMID:
18187195
14.

Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.

Schechter BA, Schrier A, Nagler RS, Smith EF, Velasquez GE.

Cornea. 2002 Jan;21(1):6-11.

PMID:
11805499
15.

Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.

Karp CL, Moore JK, Rosa RH Jr.

Ophthalmology. 2001 Jun;108(6):1093-8.

PMID:
11382635
16.

Ocular surface squamous neoplasia: to cut or not to cut.

Mills RA.

Clin Experiment Ophthalmol. 2014 May-Jun;42(4):307-8. doi: 10.1111/ceo.12349. No abstract available.

PMID:
24890086
17.
18.

Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.

Gebhardt DO.

Am J Ophthalmol. 1998 Mar;125(3):416-7. No abstract available.

PMID:
9512172
19.

Treatment of ocular surface squamous neoplasia with topical Aloe vera drops.

Damani MR, Shah AR, Karp CL, Orlin SE.

Cornea. 2015 Jan;34(1):87-9. doi: 10.1097/ICO.0000000000000296.

PMID:
25393094
20.

Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.

Karp CL, Galor A, Chhabra S, Barnes SD, Alfonso EC.

Ophthalmology. 2010 Dec;117(12):2241-6. doi: 10.1016/j.ophtha.2010.03.052.

PMID:
20619462
Items per page

Supplemental Content

Write to the Help Desk